Hostname: page-component-77c89778f8-5wvtr Total loading time: 0 Render date: 2024-07-25T05:12:43.615Z Has data issue: false hasContentIssue false
  • English
  • Français

Psychiatric medicines in India: why public healthcare facilities and a thriving generics industry cannot assure access and affordability

Published online by Cambridge University Press:  02 January 2018

Anita Kotwani
Anita Kotwani*
Affiliation:
Department of Pharmacology, V. P. Chest Institute, University of Delhi, Delhi, India, email anitakotwani@gmail.com
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

This commentary highlights the poor availability of essential psychiatric medicines at public sector facilities in India and illustrates why even a flourishing generics industry does not assure access to affordable psychiatric medicines for most Indian patients. The paper outlines the Indian government's pricing regulations and then enumerates recommendations for reform.

Type
Thematic papers
Information
International Psychiatry , Volume 9 , Issue 2 , May 2012 , pp. 34 - 36
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NCCreative Common License - ND
This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits noncommercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
Copyright
Copyright © Royal College of Psychiatrists 2012

References

Creese, A., Kotwani, A., Kutzin, J., et al (2004) Evaluating pharmaceuticals for health policy in low and middle income country settings. In Evaluating Pharmaceuticals for Health Policy and Reimbursement (eds Freemantle, N. & Hill, S.), pp. 227–243. Blackwell Publishing, BMJ Books and WHO.CrossRefGoogle Scholar
Health Action International (2011) Medicines prices, availability, affordability, and price components in NCT, Delhi – using WHO/HAI methodology. Available at http://www.haiweb.org/MedPriceDatabase/(accessed 24 March 2012).Google Scholar
Kotwani, A. (2010) Will generic drug stores improve access to essential medicines for the poor in India? Journal of Public Health Policy, 31, 178–184CrossRefGoogle ScholarPubMed
Kotwani, A., Ewen, M., Dey, D., et al (2007) Medicine prices and availability at six sites in India: using the WHO–HAI methodology. Indian Journal of Medical Research, 125, 645–654Google Scholar
Kotwani, A., Gurbani, N., Sharma, S., et al (2009) Insights for policymakers from a medicine price survey in Rajasthan. Indian Journal of Medical Research, 129, 451–454.Google ScholarPubMed
Math, S. B. & Srinivasaraju, R. (2010) Indian psychiatric epidemiological studies: learning from the past. Indian Journal of Psychiatry, 52, S95–S103.CrossRefGoogle ScholarPubMed
Patel, V. (2008) Mental health in the developing world: time for innovative thinking. Science and Development Network, 23 July. Available at http:www.scidev.net/en (accessed 4 March 2012).Google Scholar
Singal, G., Nanda, A. & Kotwani, A. (2011) A comparative evaluation of price and quality of some branded versus branded-generic medicines of the same manufacturer in India. Indian Journal of Pharmacology, 43, 131–136.Google ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.